Farms.com Home   Ag Industry News

Organic Trade Association supports proposal to expand check-off program expansion

Organic industry would decide where dollars get spent

By Diego Flammini, Farms.com

The U.S. Department of Agriculture (USDA) introduced a proposal that, if passed, would further exempt organic farmers and handlers from paying into federal research and promotion programs, also known as check-off programs.

As it stands, organic farmers, handlers, marketers, and importers are exempt from paying into the 100% organic program. If the proposal passes, it would extend to the “primary organic” label; products that are 95% organic.

The OTA (Organic Trade Association) has worked very hard to get this exemption on the books, and we are optimistic that this important regulation will now soon take effect," said Laura Batcha, CEO and Executive Director of OTA. “The organic sector is a fast-growing, distinct industry with its own unique demands for research and promotion. We're pleased USDA is moving swiftly to allow the industry to use its money to grow and develop its own sector."

Check-off programs are funded by the producers of the specific product. Notable popular ones to date are the iconic “Got Milk?” ads that feature celebrities and athletes sporting stylish milk moustaches.

Regardless that more than 80% of American families buy organic products and sales skyrocketed to $35 billion in 2013, there is room to do more.

“There is still much that needs to be done in the way of educating consumers about organic, devoting more research dollars to organic agriculture, and helping farmers to convert to organic,” Batcha said. “Giving the industry more ability to invest in its future is very significant."

The USDA published the proposed changes and there’s now a 30-day public comment period.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.